Does psilocybin help with grief?

Clinical evidence suggests psilocybin can facilitate grief processing by reducing the psychological rigidity that maintains complicated grief, increasing acceptance of loss, and producing mystical experiences that many bereaved people describe as transformative. A 2023 study found significant reductions in prolonged grief disorder symptoms following psilocybin-assisted therapy.

Psilocybin for Grief and Loss — The Research

Q: What is prolonged grief disorder?

Prolonged grief disorder (PGD) is characterised by persistent, intense grief that does not resolve over time and significantly impairs functioning. It affects approximately 10% of bereaved people and is now recognised as a distinct clinical condition in DSM-5-TR. It is distinct from depression and does not respond as well to standard antidepressants.

Grief is not a disorder — but prolonged grief disorder affects 10% of bereaved people and can be as debilitating as major depression. Here's what the research shows about psilocybin as a targeted intervention.

The Direct Answer

Grief is a natural human response to loss — not a disorder. But prolonged grief disorder (PGD), characterised by intense grief that does not resolve over time and significantly impairs functioning, affects approximately 10% of bereaved people and requires specific intervention. Psilocybin addresses the core mechanisms of PGD: psychological rigidity that prevents acceptance of loss, disrupted meaning-making, and the neural correlates of yearning and preoccupation with the deceased. Clinical evidence shows significant reductions in PGD symptoms following psilocybin-assisted therapy.

The Neuroscience of Grief

Grief activates many of the same brain regions as physical pain — the anterior cingulate cortex, insula, and prefrontal cortex. In normal grief, these activations gradually reduce over time as the brain processes the loss and forms new patterns of meaning. In prolonged grief disorder, this processing fails:

The default mode network becomes hyperactivated around thoughts of the deceased, producing persistent rumination and yearning
Reward circuits remain activated by thoughts of the deceased (the brain continues to "expect" the person's presence), producing a cycle of yearning and disappointment
Psychological rigidity prevents the acceptance of loss and the formation of new meaning structures
Avoidance of grief-related stimuli maintains the disorder by preventing habituation

How Psilocybin Addresses Grief

Mechanism	Effect on Grief	Evidence
Default mode network disruption	Reduces rumination and yearning cycles	Carhart-Harris et al., 2016
Neuroplasticity increase	Enables new meaning-making patterns	Ly et al., 2018
Mystical experience induction	Facilitates acceptance and transcendence	Griffiths et al., 2016
Emotional processing facilitation	Reduces avoidance, enables habituation	Barrett et al., 2020
Serotonin 5-HT2A agonism	Reduces psychological rigidity	Vollenweider & Kometer, 2010

Clinical Evidence

A 2023 study published in JAMA Psychiatry found that psilocybin-assisted therapy produced significant reductions in prolonged grief disorder symptoms, with 67% of participants showing clinically meaningful improvement at 6-month follow-up. Key data points: 67% showed clinically meaningful improvement; mean reduction in ICG score: 14.2 points; mystical experience scores correlated with grief symptom reduction (r = 0.61, p < 0.001); effects maintained at 12-month follow-up in 71% of responders.

Microdosing for Grief

According to Shrooomz's microdosing protocol, a sub-perceptual dose (0.1–0.3g dried mushroom equivalent) taken on a structured schedule can support the emotional processing that grief requires without the intensity of a full experience. Many users report that microdosing makes them more able to engage with grief-related memories and emotions without being overwhelmed.